HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.

Abstract
Bilateral renal denervation (BRD) has been shown to reduce hypertension and improve renal function in both human and experimental studies. We hypothesized that chronic intervention with BRD may also attenuate renal injury and fibrosis in diabetic nephropathy. This hypothesis was examined in a female streptozotocin-induced diabetic (mRen-2)27 rat (TGR) shown to capture the cardinal features of human diabetic nephropathy. Following diabetic induction, BRD/sham surgeries were conducted repeatedly (at the week 3, 6, and 9 following induction) in both diabetic and normoglycemic animals. Renal denervation resulted in a progressive decrease in systolic blood pressure from first denervation to termination (at 12 wk post-diabetic induction) in both normoglycemic and diabetic rats. Renal norepinephrine content was significantly raised following diabetic induction and ablated in denervated normoglycemic and diabetic groups. A significant increase in glomerular basement membrane thickening and mesangial expansion was seen in the diabetic kidneys; this morphological appearance was markedly reduced by BRD. Immunohistochemistry and protein densitometric analysis of diabetic innervated kidneys confirmed the presence of significantly increased levels of collagens I and IV, α-smooth muscle actin, the ANG II type 1 receptor, and transforming growth factor-β. Renal denervation significantly reduced protein expression of these fibrotic markers. Furthermore, BRD attenuated albuminuria and prevented the loss of glomerular podocin expression in these diabetic animals. In conclusion, BRD decreases systolic blood pressure and reduces the development of renal fibrosis, glomerulosclerosis, and albuminuria in this model of diabetic nephropathy. The evidence presented strongly suggests that renal denervation may serve as a therapeutic intervention to attenuate the progression of renal injury in diabetic nephropathy.
AuthorsYimin Yao, Ingrid C Fomison-Nurse, Joanne C Harrison, Robert J Walker, Gerard Davis, Ivan A Sammut
JournalAmerican journal of physiology. Renal physiology (Am J Physiol Renal Physiol) Vol. 307 Issue 3 Pg. F251-62 (Aug 01 2014) ISSN: 1522-1466 [Electronic] United States
PMID24899056 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 the American Physiological Society.
Chemical References
  • Streptozocin
  • Renin
Topics
  • Acute Kidney Injury (pathology, physiopathology, prevention & control)
  • Animals
  • Basement Membrane (pathology)
  • Denervation (methods)
  • Diabetes Mellitus, Experimental (chemically induced, complications)
  • Diabetic Nephropathies (complications, pathology, physiopathology)
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Fibrosis
  • Heterozygote
  • Kidney (innervation)
  • Kidney Glomerulus (pathology)
  • Rats
  • Rats, Transgenic
  • Renin (genetics, physiology)
  • Streptozocin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: